Although dysregulation of BMPs signaling has been linked to various types of cancers, the relationship between abnormal activation of these signaling pathways and tumorigenesis is not clear, due to conflicting findings showing BMPs promote or inhibit tumorigenesis in a cell-type and context-dependent manner. This evidence concerns the gene CLN5 and cancer.